|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 7/04 | (2006.01) |
| C07H 15/207 | (2006.01) | ||
| A61K 31/7034 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3045466 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15181545.3 |
| Date of filing the European patent application | 2007-06-21 | |
| (97) | Date of publication of the European application | 2016-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 817118 P | 2006-06-28 | US | |
| 765481 | 2007-06-20 | US |
| (72) |
GOUGOUTAS, Jack Z., US
NIRSCHL, Alexandra A., US
SINGH, Janak, US
DIMARCO, John D., US
LOBINGER, Hildegard, DE
RAMAKRISHNAN, Srividya, US
DESHPANDE, Prashant P., US
BIEN, Jeffrey T., US
LAI, Chiajen, US
WANG, Chenchi, US
RIEBEL, Peter, DE
GROSSO, John Anthony, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | (2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL PROPYLENE GLYCOL SOLVATE AS SGT2 INHIBITOR FOR THE TREATMENT OF DIABETES |
| (2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL PROPYLENE GLYCOL SOLVATE AS SGT2 INHIBITOR FOR THE TREATMENT OF DIABETES |